QA: Werewolf Therapeutics Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001785530_2022_Werewolf_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001785530')"}

Graph

Absolute values for 0001785530, Werewolf Therapeutics Inc.

  xvar xval
0 AssetsCurrent 161,068,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,913,000
3 remainder_Assets 15,269,000
4 LiabilitiesCurrent 11,874,000
5 LiabilitiesNoncurrent 14,589,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,818,000
9 ResearchAndDevelopmentExpense 35,269,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 104,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 179,250,000
1 Liabilities 26,463,000
2 Expenses 50,087,000
3 Revenues 0
4 StockholdersEquity 152,787,000
5 NetIncome -49,983,000
6 ComprehensiveNetIncome -49,983,000
7 BaseVar 127,952,000
8 EconomicCapitalRatio 2.07

Edgar->Model Mapping

Feature Distribution

Change over Time